Economic and Treatment Burden of Chronic Low-Back Pain Patients Transitioning from Short-Acting to Long-Acting Opioids or Buprenorphine Buccal Film: US Claims Analysis

Puntos clave

• This research aims to evaluate the economic and treatment burden on chronic low-back pain patients transitioning between opioid treatments.
• Analyzed US claims data from chronic low-back pain patients transitioning from short-acting opioids to either long-acting opioids or buprenorphine buccal film.
• Compared healthcare expenditures and resource utilization between the two transition groups.
• Healthcare expenditures were similar for patients transitioning to buprenorphine buccal film and long-acting opioids.
• Initiating buprenorphine buccal film may lead to lower healthcare resource utilization and reduced further short-acting opioid use.